Funder
National Institutes of Health
U.S. Department of Defense
National Institute of Neurological Disorders and Stroke
CDMRP
FRAXA Research Foundation
Subject
Neurology (clinical),Neurology
Reference84 articles.
1. Direct targeting of Galphaq and Galpha11 oncoproteins in cancer cells;Annala;Sci. Signal.,2019
2. (S)-5-(2′-Fluorophenyl)-N,N-dimethyl-1,2,3,4-tetrahydronaphthalen-2-amine, a Serotonin Receptor Modulator, Possesses Anticonvulsant, Prosocial, and Anxiolytic-like Properties in an Fmr1 Knockout Mouse Model of Fragile X Syndrome and Autism Spectrum Disorder
3. Behavioural characteristics of wild jumping or running episodes in the double mutant spontaneously epileptic rat;Asano;Lab. Anim.,1990
4. Co-occurring conditions associated with FMR1 gene variations: findings from a national parent survey;Bailey;Am. J. Med. Genet. A,2008
5. International union of basic and clinical pharmacology. CX. Classification of receptors for 5-hydroxytryptamine; pharmacology and function;Barnes;Pharmacol. Rev.,2021
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献